Missed opportunities for human papillomavirus vaccination at office visits during which influenza vaccine was administered: An AAP pediatric research in office settings (PROS) national primary care research network study.
DOI: 10.1016/j.vaccine.2020.05.090; PMCID: PMC7337558 (available on 2021-07-14)
INTRODUCTION: Little is known about missed opportunities (MOs) for HPV vaccination during primary care visits at which influenza vaccination is delivered.
METHODS: We extracted electronic health records for HPV vaccine-eligible 11-to-17-year-olds. We assessed the proportion of visits during which an influenza vaccine was given and an HPV vaccine was due, but not given (i.e., MOs).
RESULTS: Of 56,135 eligible visits, 57.5% represented MOs for HPV vaccination. MOs were more common at visits where an initial versus subsequent HPV vaccine dose was due (68.6% vs. 31.3%) and for acute/chronic and nurse-only visits compared to preventive visits (74.0% and 80.2% vs. 36.7%). In a multivariable model, MOs were more likely for the initial HPV dose and for non-preventive visits, but did not vary by patient sex/age.
CONCLUSIONS: HPV vaccine MOs were common during visits where influenza vaccine was administered. Increasing simultaneous administration of HPV and influenza vaccines could increase HPV vaccine coverage.
Human papillomavirus vaccine; Influenza vaccine; Missed opportunities; Primary care
Kelly, M., Grundmeier, R. W., Stephens-Shields, A. J., Localio, R., Shone, L. P., Wright, M., Steffes, J., Humiston, S., Rand, C., Albertin, C., Breck, A., Abney, D. E., McFarland, G., Szilagyi, P. G., Fiks, A. G. Missed opportunities for human papillomavirus vaccination at office visits during which influenza vaccine was administered: An AAP pediatric research in office settings (PROS) national primary care research network study. Vaccine 38, 5105-5108 (2020).